Please login to the form below

Not currently logged in
Email:
Password:

clinical trial

This page shows the latest clinical trial news and features for those working in and with pharma, biotech and healthcare.

New industry standards group launched

New industry standards group launched

New industry standards group launched. Align Clinical CRO will improve clinical trial collaboration. ... Biopharmaceutical solutions organisation company Syneos Health has helped to establish Align Clinical CRO, a new industry standards group which aims

Latest news

  • Alkermes slumps as FDA turns down depression drug Alkermes slumps as FDA turns down depression drug

    studies, with Alkermes’dossier relying on a third positive trial to prop up the overall data set. ... Alkermes does have another phase IIIb clinical trial ongoing with ALKS 5461, but the company’s CEO Richard Pops said until the FDA’s specific

  • Sun Pharma passes milestone with novel psoriasis drug approval Sun Pharma passes milestone with novel psoriasis drug approval

    The US regulator has approved Ilumya (tildrakizumab-asmn) for adults with moderate-to-severe psoriasis on the back of clinical trial data comparing the drug against placebo and Amgen’s TNF

  • New data could put Roche’s Tecentriq first in squamous lung cancer New data could put Roche’s Tecentriq first in squamous lung cancer

    Roche’s Tecentriq has met its targets in a clinical trial involving previously-untreated people with a form of advanced squamous lung cancer, stealing a march on its immuno-oncology rivals. ... There has been no impact on overall survival so far, the

  • Biogen pays $590m for Pfizer cognition drug Biogen pays $590m for Pfizer cognition drug

    The drug - PF-04958242 - is an AMPA receptor potentiator and glycine reuptake inhibitor heading for a phase IIb clinical trial in the second half of this year, and has already shown ... phase III, BAN2401 in phase II, and three other drugs in early-stage

  • Novartis pushes ‘virtual’ clinical trial concept Novartis pushes ‘virtual’ clinical trial concept

    Novartis pushes ‘ virtual’ clinical trial concept. Teams up with Science 37 to run ten digital-based trials over the next three years. ... an average of 11 trial site visits in six months, representing a significant burden for both patients and trial

More from news
Approximately 8 fully matching, plus 1,003 partially matching documents found.

Latest Intelligence

  • A critical juncture for clinical data management A critical juncture for clinical data management

    eTMF) systems with 70% usage and clinical trial management systems (CTMS) with 61% usage. ... Despite the drive toward clinical-data digitalisation, nearly one-third of companies report that they still use paper case-report forms.

  • The rise of real-world evidence The rise of real-world evidence

    The rise of real-world evidence. Demonstrating efficacy and value requires more than clinical trial data. ... Claims data lacks clinical outcomes. Some patient registries are unreliable and have limited follow-up.

  • Deal Watch January 2018

    Having terminated the development of its lead CAR-T therapy, JCAR015, early last year after several patient deaths in a phase II clinical trial in relapsed/refractory B-cell acute lymphoblastic ... $5m for each target for option exercise. Up to $707.5m

  • Finding the patient voice Finding the patient voice

    The report successfully pinpointed four main patient profiles, those who:. Participated in a clinical trial;. ... Clearly, empathy towards fellow patients with the same condition was the leading motivation for participating in a clinical trial.

  • Drug safety

    Healthcare terms - Drug safety.

More from intelligence
Approximately 1 fully matching, plus 101 partially matching documents found.

Latest appointments

  • Aelix Therapeutics appoints Dr Thomas Hecht Aelix Therapeutics appoints Dr Thomas Hecht

    He said: “Aelix Therapeutics has reached a crucial milestone by enrolling the first patient in the phase I clinical trial and I’m thrilled to be joining the company at this

  • Belgium's TiGenix appoints Dr Gregory Gordon Belgium's TiGenix appoints Dr Gregory Gordon

    TiGenix has also appointed Annette Valles-Sukkar as associate director, clinical projects, and both she and Dr Gordon will report to the company’s chief medical officer Dr Marie Paule Richard. ... Meanwhile, Valles-Sukkar arrives at TiGenix from

  • Nabriva Therapeutics appoints new chief commercial officer Nabriva Therapeutics appoints new chief commercial officer

    Bacterial infections focussed Nabriva Therapeutics has appointed Francesco Maria Lavino as its chief commercial officer ahead of the group’s phase III clinical trial for lefamulin - a potential new treatment for ... Lavino joins the Austrian

  • Multipharma launches Inceptua Medicines Access Multipharma launches Inceptua Medicines Access

    clinical trials of comparator sourcing, strategic planning, global depot solutions and clinical manufacturing. ... With this new addition Multipharma is poised to become a major global provider in the clinical trial services, pre-approval and unlicensed

  • Sam Agus takes up new role at Hansa Medical Sam Agus takes up new role at Hansa Medical

    With experience in medical strategy, multidisciplinary team leadership, medical marketing and clinical trial design, Agus’s therapy area expertise includes neurology, psychiatry, gastroenterology, women’s health and rare diseases.

More from appointments
Approximately 0 fully matching, plus 41 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics